Sage Therapeutics (SAGE)
(Delayed Data from NSDQ)
$7.50 USD
-0.40 (-5.06%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $7.50 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Sage Therapeutics, Inc. (SAGE) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$14.58 | $52.00 | $8.00 | 84.56% |
Price Target
Based on short-term price targets offered by 19 analysts, the average price target for Sage Therapeutics, Inc. comes to $14.58. The forecasts range from a low of $8.00 to a high of $52.00. The average price target represents an increase of 84.56% from the last closing price of $7.90.
Analyst Price Targets (19)
Broker Rating
Sage Therapeutics, Inc. currently has an average brokerage recommendation (ABR) of 2.95 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 20 brokerage firms. The current ABR compares to an ABR of 2.95 a month ago based on 22 recommendations.
Of the 20 recommendations deriving the current ABR, two are Strong Buy, representing 10% of all recommendations. A month ago, Strong Buy represented 9.09%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 3 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 16 | 16 | 18 | 17 | 16 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.95 | 2.95 | 2.95 | 2.86 | 2.77 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/14/2024 | Truist Securities | Joon Lee | Hold | Hold |
7/31/2024 | Not Identified | Not Identified | Hold | Hold |
7/30/2024 | Cowen & Co. | Ritu S Baral | Strong Buy | Hold |
7/26/2024 | Goldman Sachs | Salveen Richter | Hold | Hold |
7/25/2024 | H.C. Wainwright & Co. | Douglas Tsao | Hold | Hold |
7/25/2024 | Scotiabank | George Farmer | Strong Buy | Strong Buy |
7/24/2024 | Needham & Company | Ami Fadia | Hold | Hold |
7/19/2024 | Mizuho SecuritiesUSA | Uy D Ear | Hold | Hold |
7/9/2024 | SVB Securities | Marc Goodman | Hold | Hold |
7/9/2024 | Not Identified | Not Identified | Hold | Hold |
5/29/2024 | Not Identified | Not Identified | Not Available | Strong Sell |
5/29/2024 | Robert W. Baird & Co. | Joel L Beatty | Not Available | Hold |
4/26/2024 | Canaccord Genuity | Sumant Kulkarni | Hold | Hold |
4/25/2024 | Not Identified | Not Identified | Hold | Hold |
4/17/2024 | Wedbush Securities | Laura Chico | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.95 |
ABR (Last week) | 2.95 |
# of Recs in ABR | 20 |
Average Target Price | $14.58 |
LT Growth Rate | 20.70% |
Industry | Medical - Drugs |
Industry Rank by ABR | 84 of 253 |
Current Quarter EPS Est: | -1.54 |
SAGE FAQs
Sage Therapeutics, Inc. (SAGE) currently has an average brokerage recommendation (ABR) of 2.95 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 20 brokerage firms.
The average price target for Sage Therapeutics, Inc. (SAGE) is $14.58. The current on short-term price targets is based on 12 reports.
The forecasts for Sage Therapeutics, Inc. (SAGE) range from a low of $8 to a high of $52. The average price target represents a increase of $94.40 from the last closing price of $7.50.
The current UPSIDE for Sage Therapeutics, Inc. (SAGE) is 94.40%
Based on short-term price targets offered by 19 analysts, the average price target for Sage Therapeutics, Inc. comes to $14.58. The forecasts range from a low of $8.00 to a high of $52.00. The average price target represents an increase of 84.56% from the last closing price of $7.90.